We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Serono to Discontinue Phase III Onercept and Canvaxin Trials
Serono to Discontinue Phase III Onercept and Canvaxin Trials
April 6, 2005
Geneva-based Serono has discontinued two Phase III clinical trial programs on the recommendations of two independent data and safety monitoring boards, the company announced April 6.